ArticleExperimental hematology & oncology2012

Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR).

Axel Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.